Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer”.
Chang-Yi Lin, Hao Tian, Wan-Ying Lin, Bosen You, Jieyang Lu +7 more
Emily R. Quarato, Niloy A. Singh, Cameron Snyder, Taylor Moore, John Miller +34 more